Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment [Phase 4]

View source ↗

Summary

Clinical trial evaluating choline alfoscerate versus placebo in degenerative mild cognitive impairment (Phase 4); status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Degenerative Cognitive Impairment

Drugs mentioned

• Choline alfoscerate (choline alfoscerate)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Mild Cognitive Impairment | Phase 4 | Status: UNKNOWN